Logo image of ALBOU.PA

BOURRELIER GROUP (ALBOU.PA) Stock Fundamental Analysis

EPA:ALBOU - Euronext Paris - Matif - FR0000054421 - Common Stock - Currency: EUR

47.4  -2.6 (-5.2%)

Fundamental Rating

3

Overall ALBOU gets a fundamental rating of 3 out of 10. We evaluated ALBOU against 53 industry peers in the Specialty Retail industry. The financial health of ALBOU is average, but there are quite some concerns on its profitability. ALBOU has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

ALBOU had negative earnings in the past year.
In the past year ALBOU had a positive cash flow from operations.
Of the past 5 years ALBOU 4 years were profitable.
Each year in the past 5 years ALBOU had a positive operating cash flow.
ALBOU.PA Yearly Net Income VS EBIT VS OCF VS FCFALBOU.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M -40M 60M 80M

1.2 Ratios

Looking at the Return On Assets, with a value of -0.72%, ALBOU is in line with its industry, outperforming 49.06% of the companies in the same industry.
ALBOU has a Return On Equity (-1.24%) which is in line with its industry peers.
Industry RankSector Rank
ROA -0.72%
ROE -1.24%
ROIC N/A
ROA(3y)2.09%
ROA(5y)0.87%
ROE(3y)3.33%
ROE(5y)1.42%
ROIC(3y)N/A
ROIC(5y)N/A
ALBOU.PA Yearly ROA, ROE, ROICALBOU.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 20

1.3 Margins

In the last couple of years the Profit Margin of ALBOU has declined.
In the last couple of years the Operating Margin of ALBOU has declined.
ALBOU has a Gross Margin of 37.89%. This is comparable to the rest of the industry: ALBOU outperforms 56.60% of its industry peers.
In the last couple of years the Gross Margin of ALBOU has grown nicely.
The Profit Margin and Operating Margin are not available for ALBOU so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 37.89%
OM growth 3Y-55.81%
OM growth 5YN/A
PM growth 3Y-37.2%
PM growth 5Y-49.52%
GM growth 3Y1.89%
GM growth 5Y1.57%
ALBOU.PA Yearly Profit, Operating, Gross MarginsALBOU.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40

More info and screens

6

2. Health

2.1 Basic Checks

ALBOU does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALBOU has about the same amount of shares outstanding.
Compared to 5 years ago, ALBOU has more shares outstanding
ALBOU has a better debt/assets ratio than last year.
ALBOU.PA Yearly Shares OutstandingALBOU.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M
ALBOU.PA Yearly Total Debt VS Total AssetsALBOU.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

2.2 Solvency

ALBOU has an Altman-Z score of 2.24. This is not the best score and indicates that ALBOU is in the grey zone with still only limited risk for bankruptcy at the moment.
ALBOU has a Altman-Z score of 2.24. This is in the better half of the industry: ALBOU outperforms 64.15% of its industry peers.
A Debt/Equity ratio of 0.40 indicates that ALBOU is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.40, ALBOU is in the better half of the industry, outperforming 71.70% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF N/A
Altman-Z 2.24
ROIC/WACCN/A
WACC6.31%
ALBOU.PA Yearly LT Debt VS Equity VS FCFALBOU.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 2.95 indicates that ALBOU has no problem at all paying its short term obligations.
The Current ratio of ALBOU (2.95) is better than 88.68% of its industry peers.
ALBOU has a Quick Ratio of 2.17. This indicates that ALBOU is financially healthy and has no problem in meeting its short term obligations.
ALBOU's Quick ratio of 2.17 is amongst the best of the industry. ALBOU outperforms 90.57% of its industry peers.
Industry RankSector Rank
Current Ratio 2.95
Quick Ratio 2.17
ALBOU.PA Yearly Current Assets VS Current LiabilitesALBOU.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M

More info and screens

1

3. Growth

3.1 Past

ALBOU shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -135.75%.
The earnings per share for ALBOU have been decreasing by -46.77% on average. This is quite bad
Looking at the last year, ALBOU shows a decrease in Revenue. The Revenue has decreased by -2.02% in the last year.
The Revenue has been growing slightly by 5.44% on average over the past years.
EPS 1Y (TTM)-135.75%
EPS 3Y-36.38%
EPS 5Y-46.77%
EPS Q2Q%-72.81%
Revenue 1Y (TTM)-2.02%
Revenue growth 3Y1.3%
Revenue growth 5Y5.44%
Sales Q2Q%-0.36%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALBOU.PA Yearly Revenue VS EstimatesALBOU.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M
ALBOU.PA Yearly EPS VS EstimatesALBOU.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 0.5 1 1.5 2 2.5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALBOU. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALBOU.PA Price Earnings VS Forward Price EarningsALBOU.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

ALBOU's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. ALBOU is cheaper than 79.25% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.35
ALBOU.PA Per share dataALBOU.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40 50

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 6.42%, ALBOU is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 4.87, ALBOU pays a better dividend. On top of this ALBOU pays more dividend than 94.34% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.33, ALBOU pays a better dividend.
Industry RankSector Rank
Dividend Yield 6.42%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
ALBOU.PA Yearly Dividends per shareALBOU.PA Yearly Dividends per shareYearly Dividends per share 2018 2019 2024 1 2 3

5.3 Sustainability

DP0%
EPS Next 2YN/A
EPS Next 3YN/A
ALBOU.PA Yearly Income VS Free CF VS DividendALBOU.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M -40M 60M 80M

More info and screens

BOURRELIER GROUP

EPA:ALBOU (3/7/2025, 7:00:00 PM)

47.4

-2.6 (-5.2%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)02-26 2025-02-26
Earnings (Next)07-16 2025-07-16
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap294.83M
Analysts34.29
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.42%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1
P/FCF N/A
P/OCF 11.38
P/B 0.85
P/tB 0.96
EV/EBITDA 4.35
EPS(TTM)-0.69
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.08
FCFYN/A
OCF(TTM)4.16
OCFY8.79%
SpS47.33
BVpS55.77
TBVpS49.18
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.72%
ROE -1.24%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 37.89%
FCFM N/A
ROA(3y)2.09%
ROA(5y)0.87%
ROE(3y)3.33%
ROE(5y)1.42%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)1.67%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-55.81%
OM growth 5YN/A
PM growth 3Y-37.2%
PM growth 5Y-49.52%
GM growth 3Y1.89%
GM growth 5Y1.57%
F-Score2
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF N/A
Debt/EBITDA 6.82
Cap/Depr 89.16%
Cap/Sales 8.97%
Interest Coverage N/A
Cash Conversion 127.18%
Profit Quality N/A
Current Ratio 2.95
Quick Ratio 2.17
Altman-Z 2.24
F-Score2
WACC6.31%
ROIC/WACCN/A
Cap/Depr(3y)22.4%
Cap/Depr(5y)18.81%
Cap/Sales(3y)1.88%
Cap/Sales(5y)1.72%
Profit Quality(3y)208.14%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-135.75%
EPS 3Y-36.38%
EPS 5Y-46.77%
EPS Q2Q%-72.81%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.02%
Revenue growth 3Y1.3%
Revenue growth 5Y5.44%
Sales Q2Q%-0.36%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-268.87%
EBIT growth 3Y-55.23%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y92.36%
FCF growth 3Y-26.39%
FCF growth 5Y104.82%
OCF growth 1Y4251.12%
OCF growth 3Y-20.2%
OCF growth 5Y58.94%